Skip to main content

Table 2 Metabolic syndrome status and risk factors at baseline and review, n = 64

From: Effectiveness of a nurse practitioner-led cardiovascular prevention clinic at reduction of metabolic syndrome following maternal complications of pregnancy: a preliminary analysis

 

Baseline

Review

p-value

Metabolic syndrome present, n (%)

22 (34.4)

19 (29.7)

0.58

Number of metabolic syndrome criteria present

 0

6 (9.4)

7 (10.9)

 

 1

16 (25.0)

16 (25.0)

 

 2

19 (29.7)

22 (34.4)

 

 3

14 (21.9)

11 (17.2)

 

 4

8 (12.5)

7 (10.9)

 

 5

0 (0)

1 (1.6)

 

BMI, kg/m2

30.27 ± 7.09

30.40 ± 7.38

0.31

Waist circumference, cm

95.24 ± 14.99

95.11 ± 14.56

0.23

Peripheral SBP, mmHg

122.22 ± 13.12

120.97 ± 12.73

0.11

Peripheral DBP, mmHg

73.09 ± 10.57

73.11 ± 11.67

0.49

Triglycerides, mmol/L

1.37 ± 0.93

1.27 ± 0.71

0.18

HDL cholesterol, mmol/L

1.28 ± 0.28

1.25 ± 0.30

0.18

Glucose, mmol/L

5.20 ± 1.20

5.15 ± 0.77

0.44

Insulin, mU/L

15.22 ± 15.54

12.22 ± 7.69

0.09

HOMA-IR

3.54 ± 3.72

2.84 ± 1.99

0.24

Medicated hypertension

4 (6.3)

6 (9.4)

 

Medicated T2DM

1 (1.6)

2 (3.1)

 

Current smoking

6 (9.4)

5 (7.8)

 
  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, T2DM type 2 diabetes mellitus